China
· Delayed Price · Currency is CNY Shenzhen Mindray Bio-Medical Electronics Statistics
Total Valuation
Shenzhen Mindray Bio-Medical Electronics has a market cap or net worth of CNY 327.36 billion. The enterprise value is 314.92 billion.
| Market Cap | 327.36B |
| Enterprise Value | 314.92B |
Important Dates
The last earnings date was Tuesday, October 29, 2024.
| Earnings Date | Oct 29, 2024 |
| Ex-Dividend Date | Nov 7, 2024 |
Share Statistics
Shenzhen Mindray Bio-Medical Electronics has 1.21 billion shares outstanding. The number of shares has increased by 0.07% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 1.21B |
| Shares Change (YoY) | +0.07% |
| Shares Change (QoQ) | +0.08% |
| Owned by Insiders (%) | 55.86% |
| Owned by Institutions (%) | 32.48% |
| Float | 495.55M |
Valuation Ratios
The trailing PE ratio is 26.49 and the forward PE ratio is 23.41. Shenzhen Mindray Bio-Medical Electronics's PEG ratio is 1.57.
| PE Ratio | 26.49 |
| Forward PE | 23.41 |
| PS Ratio | 8.84 |
| PB Ratio | 8.85 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 26.74 |
| P/OCF Ratio | n/a |
| PEG Ratio | 1.57 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 21.68, with an EV/FCF ratio of 25.73.
| EV / Earnings | 25.43 |
| EV / Sales | 8.49 |
| EV / EBITDA | 21.68 |
| EV / EBIT | 23.36 |
| EV / FCF | 25.73 |
Financial Position
The company has a current ratio of 2.34, with a Debt / Equity ratio of 0.01.
| Current Ratio | 2.34 |
| Quick Ratio | 1.86 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | 0.02 |
| Debt / FCF | 0.02 |
| Interest Coverage | 733.61 |
Financial Efficiency
Return on equity (ROE) is 31.57% and return on invested capital (ROIC) is 21.22%.
| Return on Equity (ROE) | 31.57% |
| Return on Assets (ROA) | 15.66% |
| Return on Capital (ROIC) | 21.22% |
| Revenue Per Employee | 2.06M |
| Profits Per Employee | 686,378 |
| Employee Count | 18,044 |
| Asset Turnover | 0.69 |
| Inventory Turnover | 2.85 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -3.45% in the last 52 weeks. The beta is 0.18, so Shenzhen Mindray Bio-Medical Electronics's price volatility has been lower than the market average.
| Beta (5Y) | 0.18 |
| 52-Week Price Change | -3.45% |
| 50-Day Moving Average | 262.71 |
| 200-Day Moving Average | 278.61 |
| Relative Strength Index (RSI) | 48.89 |
| Average Volume (20 Days) | 8,351,010 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Shenzhen Mindray Bio-Medical Electronics had revenue of CNY 37.11 billion and earned 12.38 billion in profits. Earnings per share was 10.22.
| Revenue | 37.11B |
| Gross Profit | 24.47B |
| Operating Income | 13.48B |
| Pretax Income | 13.87B |
| Net Income | 12.38B |
| EBITDA | 14.41B |
| EBIT | 13.48B |
| Earnings Per Share (EPS) | 10.22 |
Balance Sheet
The company has 17.66 billion in cash and 300.83 million in debt, giving a net cash position of 17.36 billion or 14.35 per share.
| Cash & Cash Equivalents | 17.66B |
| Total Debt | 300.83M |
| Net Cash | 17.36B |
| Net Cash Per Share | 14.35 |
| Equity (Book Value) | 42.01B |
| Book Value Per Share | 30.59 |
| Working Capital | 15.54B |
Cash Flow
In the last 12 months, operating cash flow was 14.36 billion and capital expenditures -2.12 billion, giving a free cash flow of 12.24 billion.
| Operating Cash Flow | 14.36B |
| Capital Expenditures | -2.12B |
| Free Cash Flow | 12.24B |
| FCF Per Share | 10.12 |
Margins
Gross margin is 65.92%, with operating and profit margins of 36.32% and 33.37%.
| Gross Margin | 65.92% |
| Operating Margin | 36.32% |
| Pretax Margin | 37.38% |
| Profit Margin | 33.37% |
| EBITDA Margin | 38.83% |
| EBIT Margin | 36.32% |
| FCF Margin | 32.98% |
Dividends & Yields
This stock pays an annual dividend of 7.21, which amounts to a dividend yield of 2.61%.
| Dividend Per Share | 7.21 |
| Dividend Yield | 2.61% |
| Dividend Growth (YoY) | -18.07% |
| Years of Dividend Growth | 5 |
| Payout Ratio | 96.53% |
| Buyback Yield | -0.07% |
| Shareholder Yield | 2.54% |
| Earnings Yield | 3.77% |
| FCF Yield | 3.74% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Shenzhen Mindray Bio-Medical Electronics has an Altman Z-Score of 15.46.
| Altman Z-Score | 15.46 |
| Piotroski F-Score | n/a |